STOCK TITAN
  1. Home
  2. Sec-filings
  3. NGENF
  4. [EFFECT] NERVGEN PHARMA CORP. SEC Filing

[EFFECT] NERVGEN PHARMA CORP. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 7, 2026 4:30 P.M.
Form: F-10
CIK: 0001751912
Company Name: NERVGEN PHARMA CORP.
File Number: 333-292197

Source: View Original Filing on SEC EDGAR

Stock NGENF logo
Nervgen Pharma Corp

OTC:NGENF

NGENF Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

NGENF Latest News

Jan 8, 2026
NervGen Pharma Begins Trading on Nasdaq Today
Dec 17, 2025
NervGen Pharma Announces Filing of Form F-10 Registration Statement with The SEC Under MJDS
Dec 12, 2025
NervGen Pharma Announces Proposed Amendment to Warrants
Nov 24, 2025
NervGen Pharma Reports Third Quarter Financial Results and Provides Business Updates
Nov 24, 2025
NervGen Pharma Announces Expanded CONNECT SCI Study Data Demonstrating Unprecedented Durable Improvement in Function, Independence, and Quality of Life in Chronic Spinal Cord Injury

NGENF Latest SEC Filings

Jan 8, 2026
[6-K] NERVGEN PHARMA CORP. Current Report (Foreign Issuer)
Jan 7, 2026
[CERT] NERVGEN PHARMA CORP. Certification Filing
Jan 7, 2026
[F-10/A] NERVGEN PHARMA CORP. SEC Filing

NGENF Stock Data

194.18M
60.94M
21.96%
Biotechnology
Healthcare
Link
Canada
Vancouver